Over-The-Counter (OTC) Veterinary Drugs, also termed as non-prescription drugs are drugs that are available without any prescription.
Highlights
The global Over-The-Counter Veterinary Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Over-The-Counter Veterinary Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Over-The-Counter Veterinary Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Over-The-Counter Veterinary Drug in Veterinary Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Over-The-Counter Veterinary Drug include Merck, Zoetis, Eli Lilly, Virbac, Bayer, Sanofi, Soparfin SCA, C. H. Boehringer Sohn and Dechra Pharmaceuticals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Over-The-Counter Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-The-Counter Veterinary Drug.
The Over-The-Counter Veterinary Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Over-The-Counter Veterinary Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Over-The-Counter Veterinary Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Merck
Zoetis
Eli Lilly
Virbac
Bayer
Sanofi
Soparfin SCA
C. H. Boehringer Sohn
Dechra Pharmaceuticals
Segment by Type
Topical Drug
Oral Drug
Injectable Drug
Segment by Application
Veterinary Hospital
Veterinary Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over-The-Counter Veterinary Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over-The-Counter Veterinary Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Topical Drug
1.2.3 Oral Drug
1.2.4 Injectable Drug
1.3 Market by Application
1.3.1 Global Over-The-Counter Veterinary Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospital
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over-The-Counter Veterinary Drug Market Perspective (2018-2029)
2.2 Over-The-Counter Veterinary Drug Growth Trends by Region
2.2.1 Global Over-The-Counter Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Over-The-Counter Veterinary Drug Historic Market Size by Region (2018-2023)
2.2.3 Over-The-Counter Veterinary Drug Forecasted Market Size by Region (2024-2029)
2.3 Over-The-Counter Veterinary Drug Market Dynamics
2.3.1 Over-The-Counter Veterinary Drug Industry Trends
2.3.2 Over-The-Counter Veterinary Drug Market Drivers
2.3.3 Over-The-Counter Veterinary Drug Market Challenges
2.3.4 Over-The-Counter Veterinary Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over-The-Counter Veterinary Drug Players by Revenue
3.1.1 Global Top Over-The-Counter Veterinary Drug Players by Revenue (2018-2023)
3.1.2 Global Over-The-Counter Veterinary Drug Revenue Market Share by Players (2018-2023)
3.2 Global Over-The-Counter Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over-The-Counter Veterinary Drug Revenue
3.4 Global Over-The-Counter Veterinary Drug Market Concentration Ratio
3.4.1 Global Over-The-Counter Veterinary Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over-The-Counter Veterinary Drug Revenue in 2022
3.5 Over-The-Counter Veterinary Drug Key Players Head office and Area Served
3.6 Key Players Over-The-Counter Veterinary Drug Product Solution and Service
3.7 Date of Enter into Over-The-Counter Veterinary Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over-The-Counter Veterinary Drug Breakdown Data by Type
4.1 Global Over-The-Counter Veterinary Drug Historic Market Size by Type (2018-2023)
4.2 Global Over-The-Counter Veterinary Drug Forecasted Market Size by Type (2024-2029)
5 Over-The-Counter Veterinary Drug Breakdown Data by Application
5.1 Global Over-The-Counter Veterinary Drug Historic Market Size by Application (2018-2023)
5.2 Global Over-The-Counter Veterinary Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Over-The-Counter Veterinary Drug Market Size (2018-2029)
6.2 North America Over-The-Counter Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Over-The-Counter Veterinary Drug Market Size by Country (2018-2023)
6.4 North America Over-The-Counter Veterinary Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Over-The-Counter Veterinary Drug Market Size (2018-2029)
7.2 Europe Over-The-Counter Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Over-The-Counter Veterinary Drug Market Size by Country (2018-2023)
7.4 Europe Over-The-Counter Veterinary Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over-The-Counter Veterinary Drug Market Size (2018-2029)
8.2 Asia-Pacific Over-The-Counter Veterinary Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Over-The-Counter Veterinary Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Over-The-Counter Veterinary Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Over-The-Counter Veterinary Drug Market Size (2018-2029)
9.2 Latin America Over-The-Counter Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Over-The-Counter Veterinary Drug Market Size by Country (2018-2023)
9.4 Latin America Over-The-Counter Veterinary Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over-The-Counter Veterinary Drug Market Size (2018-2029)
10.2 Middle East & Africa Over-The-Counter Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Over-The-Counter Veterinary Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Over-The-Counter Veterinary Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Over-The-Counter Veterinary Drug Introduction
11.1.4 Merck Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Over-The-Counter Veterinary Drug Introduction
11.2.4 Zoetis Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.2.5 Zoetis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Over-The-Counter Veterinary Drug Introduction
11.3.4 Eli Lilly Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Virbac
11.4.1 Virbac Company Detail
11.4.2 Virbac Business Overview
11.4.3 Virbac Over-The-Counter Veterinary Drug Introduction
11.4.4 Virbac Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.4.5 Virbac Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Over-The-Counter Veterinary Drug Introduction
11.5.4 Bayer Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Over-The-Counter Veterinary Drug Introduction
11.6.4 Sanofi Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Soparfin SCA
11.7.1 Soparfin SCA Company Detail
11.7.2 Soparfin SCA Business Overview
11.7.3 Soparfin SCA Over-The-Counter Veterinary Drug Introduction
11.7.4 Soparfin SCA Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.7.5 Soparfin SCA Recent Development
11.8 C. H. Boehringer Sohn
11.8.1 C. H. Boehringer Sohn Company Detail
11.8.2 C. H. Boehringer Sohn Business Overview
11.8.3 C. H. Boehringer Sohn Over-The-Counter Veterinary Drug Introduction
11.8.4 C. H. Boehringer Sohn Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.8.5 C. H. Boehringer Sohn Recent Development
11.9 Dechra Pharmaceuticals
11.9.1 Dechra Pharmaceuticals Company Detail
11.9.2 Dechra Pharmaceuticals Business Overview
11.9.3 Dechra Pharmaceuticals Over-The-Counter Veterinary Drug Introduction
11.9.4 Dechra Pharmaceuticals Revenue in Over-The-Counter Veterinary Drug Business (2018-2023)
11.9.5 Dechra Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merck
Zoetis
Eli Lilly
Virbac
Bayer
Sanofi
Soparfin SCA
C. H. Boehringer Sohn
Dechra Pharmaceuticals
*If Applicable.